- Home
- HMN vs HRMY Comparison
HMN vs HRMY Comparison
Compare HMN & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HMN
- HRMY
- Stock Information
- Founded
- HMN 1945
- HRMY 2017
- Country
- HMN United States
- HRMY United States
- Employees
- HMN N/A
- HRMY N/A
- Industry
- HMN Property-Casualty Insurers
- HRMY Biotechnology: Pharmaceutical Preparations
- Sector
- HMN Finance
- HRMY Health Care
- Exchange
- HMN Nasdaq
- HRMY Nasdaq
- Market Cap
- HMN 1.8B
- HRMY 1.5B
- IPO Year
- HMN 1991
- HRMY 2020
- Fundamental
- Price
- HMN $45.79
- HRMY $34.02
- Analyst Decision
- HMN Buy
- HRMY Strong Buy
- Analyst Count
- HMN 5
- HRMY 9
- Target Price
- HMN $46.75
- HRMY $50.44
- AVG Volume (30 Days)
- HMN 250.2K
- HRMY 928.1K
- Earning Date
- HMN 11-04-2025
- HRMY 11-04-2025
- Dividend Yield
- HMN 3.04%
- HRMY N/A
- EPS Growth
- HMN 56.80
- HRMY 50.44
- EPS
- HMN 3.95
- HRMY 3.17
- Revenue
- HMN $1,675,600,000.00
- HRMY $825,944,000.00
- Revenue This Year
- HMN $7.70
- HRMY $20.68
- Revenue Next Year
- HMN $6.29
- HRMY $15.93
- P/E Ratio
- HMN $11.67
- HRMY $10.72
- Revenue Growth
- HMN 5.44
- HRMY 21.13
- 52 Week Low
- HMN $36.20
- HRMY $25.52
- 52 Week High
- HMN $48.33
- HRMY $40.93
- Technical
- Relative Strength Index (RSI)
- HMN 55.10
- HRMY 72.12
- Support Level
- HMN $44.99
- HRMY $33.39
- Resistance Level
- HMN $46.66
- HRMY $34.35
- Average True Range (ATR)
- HMN 1.17
- HRMY 1.23
- MACD
- HMN 0.12
- HRMY 0.53
- Stochastic Oscillator
- HMN 47.17
- HRMY 89.22
About HMN Horace Mann Educators Corporation
Horace Mann Educators Corp is a diversified insurance holding company that markets and underwrites personal lines of property and casualty insurance, retirement annuities, and life insurance. The company's property and casualty operations focus on automobile and homeowner insurance, while the retirement annuities are 403(b) tax-qualified products. Horace Mann Educators markets its products to kindergarten through 12th-grade teachers, administrators, and other employees of public schools and their families. The Company conducts and manages its business in four reporting segments: (1) Property & Casualty, (2) Life & Retirement, (3) Supplemental & Group Benefits and (4) Corporate & Other.
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.